The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, December 14, 2017
Trovagene announced the filing of its protocol for trial of PCM-075 in combination with abiraterone acetate for mCRPC has been submitted to the FDA.
read more
Thursday, December 14, 2017
BioSight reports positive final results in a Phase I/II multi-center, open label, dose-escalating study of its lead product BST-236.
read more
Friday, December 15, 2017
Egalet announced the FDA has granted tentative approval for an expanded label for ARYMO ER tablets C-II for long-term pain management.
read more
Friday, December 15, 2017
Amgen and LabCentral announced that Kernal Biologics and QurAlis have won the Amgen Golden Ticket at LabCentral.
read more
Monday, December 18, 2017
RXi Pharmaceuticals announced positive results with its lead clinical compound RXI-109 in a Phase 2 clinical trial.
read more
Tuesday, December 19, 2017
In recent years, the medical community has experienced a shift in the way health care is practiced.
read more
Tuesday, December 19, 2017
Second Genome has successfully completed a Phase 1 study in healthy volunteers for its lead therapeutic candidate, SGM-1019.
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more
Wednesday, December 20, 2017
EpiVax announced their latest development program for novel antigen-specific therapies, an approach which may have applications across a range of ...
read more
Wednesday, December 20, 2017
Bayer announced its collaboration partner Loxo Oncology has initiated the submission of a rolling NDA to the FDA for larotrectinib.
read more
Thursday, December 21, 2017
TARIS Biomedical and Bristol-Myers Squibb announced the companies have entered into a clinical trial collaboration to evaluate TAR-200.
read more
Thursday, December 21, 2017
Array BioPharma has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-...
read more
Friday, December 22, 2017
Santen Pharmaceutical (Japan) and Santen (USA) announced the FDA has issued a complete response letter for the NDA for intravitreal sirolimus.
read more
Tuesday, December 26, 2017
Merck KGaA announced the FDA has granted Breakthrough Therapy Designation for avelumab in combination with INLYTA.
read more
Wednesday, December 27, 2017
NeuroRx has signed a Cooperative Research and Development Agreement with the U. S. Department of Veterans Affairs.
read more